Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED BALANCE SHEETS

v3.20.4
CONSOLIDATED BALANCE SHEETS
$ in Thousands
Dec. 31, 2019
USD ($)
CURRENT ASSETS  
Cash and cash equivalents $ 1,769
Accounts receivable, net 2,150
Inventories, net 7,971
Investment in marketable securities 27,929
Prepaid expenses and other current assets 1,402
Total current assets 41,221
Property and equipment, net 151
Equity method investment 13,325
Right of use assets 4,474
Other assets 285
Total assets 59,456
CURRENT LIABILITIES  
Accounts payable and accrued expenses 11,498
Operating lease liabilities, current portion 991
Other current liabilities 5,748
Revolving line of credit to related party 600
Warrant derivative liabilities 38
Notes payable, net of discount 3,749
Notes payable to related parties 193
Convertible debentures, net of discount 7,015
Convertible notes payable, net of discount 2,995
Total current liabilities 32,827
Operating lease liabilities, less current portion 3,932
Other long-term liabilities 33,750
Total liabilities 70,509
STOCKHOLDERS’ EQUITY (DEFICIT)  
Preferred stock — par value $0.001 per share, 15,000,000 shares authorized, no shares issued or outstanding
Common stock — par value $0.001 per share, 250,000,000 shares authorized, 48,471,446 shares and 37,341,393 shares issued and outstanding at December 31, 2019 and at December 31, 2018, respectively 48
Additional paid-in capital 215,207
Accumulated other comprehensive income (loss) (79)
Accumulated deficit (226,229)
Total stockholders’ deficit (11,053)
Total liabilities and stockholders’ deficit $ 59,456